Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Corvus Pharmaceuticals, Inc. (CRVS)
Sector: Healthcare; Industry: Biotechnology

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that is in Phase I/Ib clinical trial for adenosine, an immune checkpoint.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-17 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 1,285,714 $3.50 $4,499,999 No
2021-02-17 Thompson Peter A. 10%-Owner, Director Buy 1,285,714 $3.50 $4,499,999 No
2021-02-17 MILLER RICHARD A MD President and CEO Buy 100,000 $3.50 $350,000 No
2020-07-08 Novo Holdings A/S 10%-Owner Sell 1,538,062 $5.31 $8,168,547 No
2019-11-13 MILLER RICHARD A MD President and CEO Buy 15,008 $3.00 $45,029 No
2019-08-06 Thompson Peter A. 10%-Owner, Director Buy 142,656 $3.51 $500,723 No
2019-08-06 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 142,656 $3.51 $500,723 No
2019-08-07 MILLER RICHARD A MD President and CEO Buy 7,500 $3.56 $26,725 No
2019-07-25 Novo Holdings A/S 10%-Owner Sell 1,492,956 $4.07 $6,077,845 No
2019-07-01 Thompson Peter A. 10%-Owner, Director Buy 657,344 $3.72 $2,444,065 No
2019-07-01 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 657,344 $3.72 $2,444,065 No
2019-06-14 MILLER RICHARD A MD President and CEO Buy 12,000 $3.41 $40,874 No
2019-06-11 MILLER RICHARD A MD President and CEO Buy 15,212 $3.49 $53,039 No
2019-06-07 LEA LEIV Chief Financial Officer Buy 25,500 $3.49 $88,980 No
2018-12-27 MILLER RICHARD A MD President and CEO Buy 20,000 $3.29 $65,884 No
2018-12-21 LEA LEIV Chief Financial Officer Buy 24,700 $4.15 $102,409 No
2018-12-20 MILLER RICHARD A MD President and CEO Buy 10,000 $4.39 $43,950 No
2018-12-06 MILLER RICHARD A MD President and CEO Buy 5,000 $5.99 $29,934 No
2018-12-04 MILLER RICHARD A MD President and CEO Buy 1,502 $5.95 $8,937 No
2018-03-12 Thompson Peter A. 10%-Owner, Director Buy 588,235 $8.50 $4,999,998 No
2018-03-12 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 588,235 $8.50 $4,999,998 No
2018-03-12 Novo Holdings A/S 10%-Owner Buy 1,176,470 $8.50 $9,999,995 No
2018-03-12 Gould Terry P 10%-Owner, Director Buy 588,235 $8.50 $4,999,998 No
2018-03-12 ADAMS STREET PARTNERS LLC 10%-Owner Buy 588,235 $8.50 $4,999,998 No
2018-03-12 MILLER RICHARD A MD President and CEO Buy 100,000 $8.50 $850,000 No
2017-11-20 MILLER RICHARD A MD President and CEO Buy 10,000 $10.79 $107,850 No
2017-06-23 Novo Holdings A/S 10%-Owner Buy 20,000 $10.95 $219,000 No
2017-06-13 MILLER RICHARD A MD President and CEO Buy 25,000 $9.88 $247,084 No
2016-06-24 Thompson Peter A. 10%-Owner, Director Buy 1,000 $12.98 $12,983 No
2016-06-24 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 1,000 $12.98 $12,983 No

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.